关于 VACCINOGEN INC
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI.
Source: Wikipedia
行业Biotechnology
总部Frederick, MD
成立2007
法律形式C Corporation
状态营业中
关键数据
法律信息
| 法定名称 | VACCINOGEN INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1453001在 SEC EDGAR 上查看 ↗ |
| 注册地址 | Frederick, MD |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Nov. 14, 2026